MX167455B - Procedimiento para la preparacion de acidos oxoftalazinil aceticos - Google Patents

Procedimiento para la preparacion de acidos oxoftalazinil aceticos

Info

Publication number
MX167455B
MX167455B MX020672A MX2067290A MX167455B MX 167455 B MX167455 B MX 167455B MX 020672 A MX020672 A MX 020672A MX 2067290 A MX2067290 A MX 2067290A MX 167455 B MX167455 B MX 167455B
Authority
MX
Mexico
Prior art keywords
preparation
oxoftalazinyl
procedure
acetic acids
formula
Prior art date
Application number
MX020672A
Other languages
English (en)
Inventor
Banavara Lakshamana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX167455B publication Critical patent/MX167455B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a un procedimiento para la preparación de ácidos oxoftalazinil acéticos de la fórmula: I caracterizado por hacer reaccionar un compuesto de la fórmula: IIB con un compuesto de la fórmula: III
MX020672A 1989-05-11 1990-05-11 Procedimiento para la preparacion de acidos oxoftalazinil aceticos MX167455B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,997 US4954629A (en) 1989-05-11 1989-05-11 Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Publications (1)

Publication Number Publication Date
MX167455B true MX167455B (es) 1993-03-23

Family

ID=23379152

Family Applications (2)

Application Number Title Priority Date Filing Date
MX020672A MX167455B (es) 1989-05-11 1990-05-11 Procedimiento para la preparacion de acidos oxoftalazinil aceticos
MX9207687A MX9207687A (es) 1989-05-11 1992-12-31 Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX9207687A MX9207687A (es) 1989-05-11 1992-12-31 Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos.

Country Status (30)

Country Link
US (1) US4954629A (es)
EP (1) EP0397350B1 (es)
JP (1) JPH035479A (es)
KR (1) KR920006419B1 (es)
CN (1) CN1025855C (es)
AR (1) AR246968A1 (es)
AT (1) ATE103913T1 (es)
AU (2) AU618898B2 (es)
BG (1) BG50609A3 (es)
CA (1) CA2016504C (es)
CZ (1) CZ281213B6 (es)
DD (1) DD294257A5 (es)
DE (1) DE69007846T2 (es)
DK (1) DK0397350T3 (es)
EG (1) EG19082A (es)
ES (1) ES2063265T3 (es)
FI (1) FI93959C (es)
HU (1) HU212304B (es)
IE (1) IE62591B1 (es)
IL (3) IL94301A (es)
MX (2) MX167455B (es)
NO (1) NO177708C (es)
NZ (1) NZ233597A (es)
PH (1) PH26567A (es)
PL (1) PL164427B1 (es)
PT (1) PT93985B (es)
RO (1) RO107256B1 (es)
RU (1) RU2014333C1 (es)
YU (1) YU91290A (es)
ZA (1) ZA903565B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
EP2593456B1 (en) 2010-07-16 2016-11-30 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
CN102558184B (zh) * 2011-12-30 2014-07-16 西南大学 酞嗪类衍生物的合成方法
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
EP3352754B1 (en) 2016-06-21 2020-09-02 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and methods of use thereof
AU2018307964B2 (en) 2017-07-28 2023-11-16 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
WO2020205846A1 (en) 2019-04-01 2020-10-08 Applied Therapeutics Inc. Inhibitors of aldose reductase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3337859A1 (de) * 1983-01-21 1984-07-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzthiazolen
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Also Published As

Publication number Publication date
FI93959B (fi) 1995-03-15
CA2016504A1 (en) 1990-11-11
EG19082A (en) 1994-07-30
YU91290A (sh) 1992-09-07
US4954629A (en) 1990-09-04
KR920006419B1 (ko) 1992-08-06
CN1047499A (zh) 1990-12-05
CZ281213B6 (cs) 1996-07-17
PL164427B1 (pl) 1994-07-29
CN1025855C (zh) 1994-09-07
JPH0573753B2 (es) 1993-10-15
DE69007846T2 (de) 1994-07-28
AU8680691A (en) 1992-01-02
CA2016504C (en) 1999-07-27
FI902333A0 (fi) 1990-05-10
JPH035479A (ja) 1991-01-11
MX9207687A (es) 1994-06-30
PT93985A (pt) 1991-01-08
EP0397350B1 (en) 1994-04-06
HU212304B (en) 1996-05-28
BG50609A3 (en) 1992-09-15
DK0397350T3 (da) 1994-05-09
AU626225B2 (en) 1992-07-23
RU2014333C1 (ru) 1994-06-15
DD294257A5 (de) 1991-09-26
IL94301A (en) 1996-01-19
PH26567A (en) 1992-08-19
PT93985B (pt) 1996-11-29
NO902071D0 (no) 1990-05-10
AR246968A1 (es) 1994-10-31
ATE103913T1 (de) 1994-04-15
FI93959C (fi) 1995-06-26
RO107256B1 (ro) 1993-10-30
IL114271A0 (en) 1995-10-31
EP0397350A1 (en) 1990-11-14
AU618898B2 (en) 1992-01-09
KR900018114A (ko) 1990-12-20
AU5490690A (en) 1990-11-15
IE901626L (en) 1990-11-11
CZ227890A3 (en) 1996-04-17
NO177708C (no) 1995-11-08
NO177708B (no) 1995-07-31
IE62591B1 (en) 1995-02-08
HU902995D0 (en) 1990-09-28
NZ233597A (en) 1992-02-25
DE69007846D1 (de) 1994-05-11
ZA903565B (en) 1991-12-24
NO902071L (no) 1990-11-12
ES2063265T3 (es) 1995-01-01
PL285113A1 (en) 1991-07-15
IL114271A (en) 1998-04-05
HUT54690A (en) 1991-03-28
IL94301A0 (en) 1991-03-10

Similar Documents

Publication Publication Date Title
MX168599B (es) Procedimiento para la preparacion de compuestos cefemicos
AR240830A2 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
ES439017A1 (es) Un procedimiento para la preparacion de nuevas piridinas.
MX167455B (es) Procedimiento para la preparacion de acidos oxoftalazinil aceticos
DE69802231T2 (de) Verfahren zur Herstellung von Aminobenzol-Derivaten
DE69033069D1 (de) Prostaglandinanaloge
NZ240632A (en) Purification of an ester mixture by reacting carbonyl compounds therein with an aqueous amino compound to form water-soluble products, followed by distillation
WO1993009111A3 (en) Novel methods for the preparation of glycerol carbonate esters
DE3664212D1 (en) Process for preparing l-homoalanin-4-yl(methyl)-phosphinic acids, as well as their alkyl esters
GR3001445T3 (en) N-glycolylneuraminic acid derivative
MY101645A (en) Phosphoric esters and process for preparing the same.
ES8703475A1 (es) Un procedimiento para la preparacion de derivados de 5-cetomilbemicina.
MY105374A (en) A process for the preparation of 7-amino-3-methoxymeth- yl-ceph-3-em-4-carboxylic acid.
PT76027A (en) Process for the preparation of n-propanoldiamine ethers
ES8704970A1 (es) Procedimiento para preparar acidos corticosteroide-21-fosforicos.
DE3173904D1 (en) Esters of n-(4'-hydroxyphenyl)acetamide with 5-benzoyl-1-methylpyrrole-2-acetic acids
PT798297E (pt) "processo para a producao de 2-alcoxi-6-(trifluorometil)-pirimidin-4-ol"
FR2453159A1 (fr) Procede de preparation de 2-aminopyrazines substituees
ZA872591B (en) Process for the preparation of alpha-aminoalkylphosphonic acids
IN170286B (es)
GR81771B (es)
FR2367770A1 (fr) Procede de preparation d'acides alcenylphosphiniques
ES2018745A6 (es) Procedimiento para la obtencion de n-carboximetilglicina y sus sales.
FR2453160A1 (fr) Procede de preparation de quinazolinones
DE3068679D1 (en) Process for the production of branched s-alkyl phosphonodithioic halide intermediates